Home/Filings/4/0001562180-23-005268
4//SEC Filing

Lee Jacks 4

Accession 0001562180-23-005268

CIK 0001560241other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:06 PM ET

Size

10.9 KB

Accession

0001562180-23-005268

Insider Transaction Report

Form 4
Period: 2023-06-15
Lee Jacks
Director
Transactions
  • Award

    Common Stock

    2023-06-15+10,00010,000 total
  • Award

    Stock Options (Right to Buy)

    2023-06-15+30,00030,000 total
    Exercise: $2.83Exp: 2033-06-15Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001935943

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:06 PM ET
Size
10.9 KB